1. Home
  2. CAE vs CYTK Comparison

CAE vs CYTK Comparison

Compare CAE & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAE
  • CYTK
  • Stock Information
  • Founded
  • CAE 1947
  • CYTK 1997
  • Country
  • CAE Canada
  • CYTK United States
  • Employees
  • CAE N/A
  • CYTK N/A
  • Industry
  • CAE
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAE
  • CYTK Health Care
  • Exchange
  • CAE Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • CAE 6.1B
  • CYTK 6.0B
  • IPO Year
  • CAE N/A
  • CYTK 2004
  • Fundamental
  • Price
  • CAE $23.01
  • CYTK $49.16
  • Analyst Decision
  • CAE Buy
  • CYTK Buy
  • Analyst Count
  • CAE 3
  • CYTK 16
  • Target Price
  • CAE $27.33
  • CYTK $83.67
  • AVG Volume (30 Days)
  • CAE 561.5K
  • CYTK 1.2M
  • Earning Date
  • CAE 11-12-2024
  • CYTK 11-06-2024
  • Dividend Yield
  • CAE N/A
  • CYTK N/A
  • EPS Growth
  • CAE N/A
  • CYTK N/A
  • EPS
  • CAE N/A
  • CYTK N/A
  • Revenue
  • CAE $3,279,099,891.00
  • CYTK $3,219,000.00
  • Revenue This Year
  • CAE $8.04
  • CYTK N/A
  • Revenue Next Year
  • CAE $5.99
  • CYTK $911.39
  • P/E Ratio
  • CAE N/A
  • CYTK N/A
  • Revenue Growth
  • CAE 4.74
  • CYTK N/A
  • 52 Week Low
  • CAE $15.95
  • CYTK $30.68
  • 52 Week High
  • CAE $22.83
  • CYTK $110.25
  • Technical
  • Relative Strength Index (RSI)
  • CAE 80.41
  • CYTK 39.67
  • Support Level
  • CAE $21.40
  • CYTK $49.64
  • Resistance Level
  • CAE $22.11
  • CYTK $59.39
  • Average True Range (ATR)
  • CAE 0.59
  • CYTK 2.23
  • MACD
  • CAE 0.40
  • CYTK -0.54
  • Stochastic Oscillator
  • CAE 97.00
  • CYTK 4.88

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: